US 11,732,000 B2
Oxysterols and methods of use thereof
Francesco G. Salituro, Marlborough, MA (US); Albert Jean Robichaud, Boston, MA (US); Gabriel Martinez Botella, Wayland, MA (US); and Boyd L. Harrison, Princeton Junction, NJ (US)
Assigned to Sage Therapeutics, Inc., Cambridge, MA (US)
Filed by Sage Therapeutics, Inc., Cambridge, MA (US)
Filed on Aug. 6, 2021, as Appl. No. 17/396,034.
Application 17/396,034 is a continuation of application No. 15/742,424, granted, now 11,117,924, previously published as PCT/US2016/041175, filed on Jul. 6, 2016.
Claims priority of provisional application 62/332,931, filed on May 6, 2016.
Claims priority of provisional application 62/189,068, filed on Jul. 6, 2015.
Prior Publication US 2022/0048943 A1, Feb. 17, 2022
Int. Cl. C07J 9/00 (2006.01); C07J 7/00 (2006.01); A61P 23/00 (2006.01); A61P 25/20 (2006.01); A61P 3/00 (2006.01); C07J 17/00 (2006.01); C07J 31/00 (2006.01); C07J 13/00 (2006.01); C07J 41/00 (2006.01)
CPC C07J 9/00 (2013.01) [A61P 3/00 (2018.01); A61P 23/00 (2018.01); A61P 25/20 (2018.01); C07J 17/00 (2013.01); C07J 7/002 (2013.01); C07J 9/005 (2013.01); C07J 13/005 (2013.01); C07J 13/007 (2013.01); C07J 31/006 (2013.01); C07J 41/0061 (2013.01)] 12 Claims
 
1. A compound selected from the group consisting of:

OG Complex Work Unit Chemistry